HARROW, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.53 USD | +5.30% |
|
+0.77% | -5.98% |
| Apr. 11 | Craig-Hallum Starts Harrow With Buy Rating, $24 Price Target | MT |
| Mar. 22 | B. Riley Securities Adjusts Harrow Health's Price Target to $26 From $30, Maintains Buy Rating | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 195.8 | 176.6 | 232.4 | 439.7 | 393.3 | 372.4 | - | - |
| Enterprise Value (EV) 1 | 195.8 | 176.6 | 232.4 | 439.7 | 393.3 | 372.4 | 372.4 | 372.4 |
| P/E ratio | 778 x | -52.8 x | -12.5 x | -28.9 x | -14.9 x | -32.7 x | 17.7 x | 5.98 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 3.83 x | 3.61 x | 3.21 x | 4.96 x | 3.02 x | 2.02 x | 1.48 x | 1.23 x |
| EV / Revenue | 3.83 x | 3.61 x | 3.21 x | 4.96 x | 3.02 x | 2.02 x | 1.48 x | 1.23 x |
| EV / EBITDA | 42.7 x | 30.9 x | 11.9 x | 33.8 x | 14 x | 9.94 x | 5.01 x | 3.05 x |
| EV / FCF | - | - | 70.5 x | - | - | 44.3 x | 11.3 x | - |
| FCF Yield | - | - | 1.42% | - | - | 2.26% | 8.86% | - |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 25,173 | 25,746 | 26,903 | 29,790 | 35,118 | 35,363 | - | - |
| Reference price 2 | 7.780 | 6.860 | 8.640 | 14.76 | 11.20 | 10.53 | 10.53 | 10.53 |
| Announcement Date | 3/13/20 | 3/8/21 | 3/10/22 | 3/23/23 | 3/19/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 51.16 | 48.87 | 72.48 | 88.6 | 130.2 | 184.8 | 251.3 | 303 |
| EBITDA 1 | 4.583 | 5.715 | 19.5 | 13.02 | 28.12 | 37.47 | 74.26 | 121.9 |
| EBIT 1 | -4.803 | 0.385 | 1.614 | 1.919 | 0.431 | 7.452 | 44.13 | 93.55 |
| Operating Margin | -9.39% | 0.79% | 2.23% | 2.17% | 0.33% | 4.03% | 17.56% | 30.88% |
| Earnings before Tax (EBT) 1 | -0.125 | -3.415 | -17.87 | -14.01 | -23.71 | -12.32 | 27.66 | 83.12 |
| Net income 1 | 0.168 | -3.357 | -18.48 | -14.09 | -24.41 | -11.97 | 22.99 | 78.14 |
| Net margin | 0.33% | -6.87% | -25.5% | -15.9% | -18.75% | -6.48% | 9.15% | 25.79% |
| EPS 2 | 0.0100 | -0.1300 | -0.6900 | -0.5100 | -0.7500 | -0.3225 | 0.5933 | 1.760 |
| Free Cash Flow 1 | - | - | 3.296 | - | - | 8.4 | 33 | - |
| FCF margin | - | - | 4.55% | - | - | 4.55% | 13.13% | - |
| FCF Conversion (EBITDA) | - | - | 16.91% | - | - | 22.42% | 44.44% | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | 143.53% | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 3/13/20 | 3/8/21 | 3/10/22 | 3/23/23 | 3/19/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 18.71 | 20.19 | 22.12 | 23.32 | 22.82 | 20.33 | 26.1 | 33.47 | 34.26 | 36.36 | 37.27 | 43.2 | 48.36 | 55.93 | 56.6 |
| EBITDA 1 | 4.922 | 4.599 | 4.94 | 4.505 | -1.021 | 1.089 | 5.342 | 11 | 9.209 | 2.563 | 3.864 | 7.786 | 11.28 | 14.5 | 14.43 |
| EBIT 1 | -3.717 | -1.755 | 2.101 | 1.69 | -0.094 | -1.778 | 1.21 | 2.352 | 1.744 | -4.875 | -2.43 | 0.0055 | 3.603 | 6.272 | 6.925 |
| Operating Margin | -19.87% | -8.69% | 9.5% | 7.25% | -0.41% | -8.75% | 4.64% | 7.03% | 5.09% | -13.41% | -6.52% | 0.01% | 7.45% | 11.21% | 12.23% |
| Earnings before Tax (EBT) 1 | -8.328 | -7.285 | -2.438 | -6.199 | -6.429 | 1.055 | -6.931 | -4.244 | -2.852 | -9.683 | -7.418 | -5.232 | -1.701 | 2.005 | 2.185 |
| Net income 1 | -8.328 | -7.418 | -2.438 | -6.239 | -6.464 | 1.055 | -6.643 | -4.229 | -4.391 | -9.148 | -7.288 | -4.892 | -1.71 | 1.87 | 1.69 |
| Net margin | -44.51% | -36.74% | -11.02% | -26.75% | -28.32% | 5.19% | -25.45% | -12.64% | -12.81% | -25.16% | -19.56% | -11.33% | -3.54% | 3.34% | 2.99% |
| EPS 2 | -0.3100 | -0.2700 | -0.0900 | -0.2300 | -0.2400 | 0.0400 | -0.2200 | -0.1400 | -0.1300 | -0.2600 | -0.2000 | -0.1375 | -0.0450 | 0.0475 | 0.0450 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/9/21 | 3/10/22 | 5/5/22 | 8/9/22 | 11/14/22 | 3/23/23 | 5/11/23 | 8/9/23 | 11/13/23 | 3/19/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | 3.3 | - | - | 8.4 | 33 | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | - | - | 1.79 | 2.6 | - | 0.9 | 0.77 | - |
| Capex / Sales | - | - | 2.46% | 2.93% | - | 0.49% | 0.31% | - |
| Announcement Date | 3/13/20 | 3/8/21 | 3/10/22 | 3/23/23 | 3/19/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
10.53
USD
Average target price
26.65
USD
Spread / Average Target
+153.09%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -5.98% | 372M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- HROW Stock
- Financials Harrow, Inc.
